Changeflow GovPing Pharma & Drug Safety Novel Heterocyclic Compounds for Pharmaceutical...
Routine Notice Added Final

Novel Heterocyclic Compounds for Pharmaceutical Use

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

Hoffmann-La Roche Inc. published patent application US20260092076A1 for novel heterocyclic compounds with pharmaceutical use. The application covers compounds having general formula I with defined R1, R2, R3, A and W substituents, related compositions, and methods of using the compounds. Filing date was October 7, 2025, under Application No. 19351608.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Hoffmann-La Roche Inc. published patent application US20260092076A1 covering novel heterocyclic compounds of general formula I for pharmaceutical use. The application lists eight inventors and includes CPC classifications related to heterocyclic compounds (C07D 519/00, C07D 498/04) and various A61K therapeutic categories. The assignee is Hoffmann-La Roche Inc.

This is a routine patent application publication providing public notice of the filing. No compliance action is required from third parties. Pharmaceutical companies and drug manufacturers may wish to review the claims to assess potential freedom-to-operate implications or competitive landscape awareness. The application publication date is April 2, 2026.

Archived snapshot

Apr 2, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

NOVEL COMPOUNDS

Application US20260092076A1 Kind: A1 Apr 02, 2026

Assignee

Hoffmann-La Roche Inc.

Inventors

Lewis Scott AITKEN, Lea Aurelie BOUCHE, Wolfgang GUBA, Georg Stefan JAESCHKE, Stefanie Katharina MESCH, Christian SCHNIDER, Jonathan Martin SHANNON, Sandra STEINER

Abstract

The invention relates to novel compounds having the general formula I wherein R1, R2, R3, A and W are as described herein, composition including the compounds and methods of using the compounds.

CPC Classifications

C07D 519/00 A61K 31/437 A61K 31/4375 A61K 31/4725 A61K 31/4985 A61K 31/5025 A61K 31/519 C07D 498/04

Filing Date

2025-10-07

Application No.

19351608

View original document →

Named provisions

General Formula I Abstract - Novel Compounds

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 2nd, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260092076A1 / Application No. 19351608

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Patent Filing Pharmaceutical Compounds
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!